BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29967375)

  • 1. Early alteration of epigenetic-related transcription in Huntington's disease mouse models.
    Hervás-Corpión I; Guiretti D; Alcaraz-Iborra M; Olivares R; Campos-Caro A; Barco Á; Valor LM
    Sci Rep; 2018 Jul; 8(1):9925. PubMed ID: 29967375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes.
    Guiretti D; Sempere A; Lopez-Atalaya JP; Ferrer-Montiel A; Barco A; Valor LM
    Neurobiol Dis; 2016 May; 89():190-201. PubMed ID: 26851501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
    Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
    Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice.
    Achour M; Le Gras S; Keime C; Parmentier F; Lejeune FX; Boutillier AL; Néri C; Davidson I; Merienne K
    Hum Mol Genet; 2015 Jun; 24(12):3481-96. PubMed ID: 25784504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1.
    Laprairie RB; Petr GT; Sun Y; Fischer KD; Denovan-Wright EM; Rosenberg PA
    Neurochem Int; 2019 Feb; 123():85-94. PubMed ID: 29709465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice.
    Denovan-Wright EM; Robertson HA
    Neuroscience; 2000; 98(4):705-13. PubMed ID: 10891614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington's disease.
    Yildirim F; Ng CW; Kappes V; Ehrenberger T; Rigby SK; Stivanello V; Gipson TA; Soltis AR; Vanhoutte P; Caboche J; Housman DE; Fraenkel E
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24840-24851. PubMed ID: 31744868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.
    Vodicka P; Mo S; Tousley A; Green KM; Sapp E; Iuliano M; Sadri-Vakili G; Shaffer SA; Aronin N; DiFiglia M; Kegel-Gleason KB
    J Huntingtons Dis; 2015; 4(2):187-201. PubMed ID: 26397899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature.
    Le Gras S; Keime C; Anthony A; Lotz C; De Longprez L; Brouillet E; Cassel JC; Boutillier AL; Merienne K
    Sci Rep; 2017 Feb; 7():42875. PubMed ID: 28225006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington's disease.
    McFarland KN; Das S; Sun TT; Leyfer D; Kim MO; Xia E; Sangrey GR; Kuhn A; Luthi-Carter R; Clark TW; Sadri-Vakili G; Cha JH
    J Huntingtons Dis; 2013; 2(3):263-77. PubMed ID: 25062675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of nucleosome dynamics in Huntington's disease.
    Stack EC; Del Signore SJ; Luthi-Carter R; Soh BY; Goldstein DR; Matson S; Goodrich S; Markey AL; Cormier K; Hagerty SW; Smith K; Ryu H; Ferrante RJ
    Hum Mol Genet; 2007 May; 16(10):1164-75. PubMed ID: 17403718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
    Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ
    Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional and subcellular distribution of GABA
    Kumar U; Heer M; Somvanshi RK
    Neurosci Lett; 2017 Feb; 640():81-87. PubMed ID: 28104430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
    Ferrante A; Martire A; Pepponi R; Varani K; Vincenzi F; Ferraro L; Beggiato S; Tebano MT; Popoli P
    Neurobiol Dis; 2014 Nov; 71():193-204. PubMed ID: 25132555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
    Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
    J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics of Huntington's Disease.
    Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M
    Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis.
    Kreilaus F; Spiro AS; Hannan AJ; Garner B; Jenner AM
    J Huntingtons Dis; 2015; 4(4):305-18. PubMed ID: 26639223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease.
    Buckley NJ; Johnson R; Zuccato C; Bithell A; Cattaneo E
    Neurobiol Dis; 2010 Jul; 39(1):28-39. PubMed ID: 20170730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse.
    Sadri-Vakili G; Menon AS; Farrell LA; Keller-McGandy CE; Cantuti-Castelvetri I; Standaert DG; Augood SJ; Yohrling GJ; Cha JH
    Eur J Neurosci; 2006 Jun; 23(12):3171-5. PubMed ID: 16820007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.